HemosIL LMW Heparin Controls; Part Number: 0020300200;
Published August 20, 2025 · Recall initiated: February 3, 2025
Summary
FDA records medical device Class II recall Z-2323-2025, published August 20, 2025 and initiated February 3, 2025. Recalling firm: Instrumentation Laboratory; Status: Ongoing; Reported quantity: 41,824 units; Lot: Part Number: 0020300200; UDI-DI: 08426950472490; Lot Numbers: N0330228, N0632773, N0935135, N1036592, N0148986, N0441476, N0643673, N0845161, N1147397. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Instrumentation Laboratory
- Distributor
- Worldwide - US Nationwide and the countries of Algeria, Andorra, Argentina, Australia, Austria, Belarus, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Finland, Germany, Gibraltar, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Kyrgyzstan, Lebanon, Lithuania, Macao, Malaysia, Mexico, Panama, Paraguay, Peru, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, Vietnam.
- Lot
- Part Number: 0020300200; UDI-DI: 08426950472490; Lot Numbers: N0330228, N0632773, N0935135, N1036592, N0148986, N0441476, N0643673, N0845161, N1147397;
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHemoslL AcuStar HIT-lgG(PF-4). Part Number: 0009802028. in vitro diagnostic (OUS only)October 21, 2026
- FDAHemoslL AcuStar HIT-lgG(PF-4). Part Number: 0009800127. in vitro diagnosticOctober 21, 2026
- FDAGEM Premier 7000 with iQM3 Part Numbers: 00077407508 00077407510 00077415004 00077415008 00077415010August 12, 2026
- FDAGEM Premier 5000 PAK Part Numbers: 00055360010 00055360011 00055407504 00055415010 00055430010 00055430011August 12, 2026
- FDAGE SIGNA Hero XT (China Only), Nuclear Magnetic Resonance Imaging SystemAugust 20, 2025
- FDAZvu Anorectal Manometry Procedure Kit, REF: HRAM-PROC-10August 20, 2025
Questions about this recall
Was HemosIL LMW Heparin Controls; Part Number: 0020300200; recalled?
Yes. FDA published recall Z-2323-2025 on August 20, 2025. Reported hazard: Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.
What should I do if I have this product?
Voluntary: Firm initiated · Letter